Ophthalmological Agent Toxicity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ophthalmological Agent Toxicity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 4

NCT06859476

Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes

Demonstrate the non-inferiority of Manzanilla Sophia® compared to Meticel Ofteno® 0.5% in providing a sensation of eye relief, through the score of an analogous…

Mexico167 participantsStarted 2025-05-23

Treatment: Manzanilla Sophia®, Meticel Ofteno® 0.5%

CompletedPhase 1

NCT06363292

Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects

This is a phase I clinical study evaluating the safety and tolerability of PRO-231 ophthalmic solution through the incidence of unexpected adverse events, incid…

Mexico37 participantsStarted 2024-01-30

Treatment: PRO-231, VIGAMOXI®